Hyloris Pharmaceuticals S.A.

HYL.BR · BRU
Analyze with AI
€5.94−€0.04 (−0.67%)
At close:Dec 19, 2025, 3:36 PM UTC
P/E TTM-25.33
P/B TTM5.62
P/S TTM19.03
Dividend Yield0%
EPS-€0.24
Beta0.262
Valuation
PEG Ratio5.57
FCF Yield-4.03%
EV / EBITDA-33.65
More On Valuation »
Quality
ROIC-22.07%
Gross Margin97.17%
Cash Conv. Ratio1.04
More On Quality »
Growth
Revenue 3Y CAGR50.41%
FCF Growth48.63%
More On Growth »
Safety
Net Debt / EBITDA3.82
Interest Coverage0.00
More On Safety »
Efficiency
Inventory Turnover1.99
Cash Conv. Cycle-3,090.41
More On Efficiency »

Hyloris Pharmaceuticals S.A. (HYL.BR) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Hyloris Pharmaceuticals S.A. (HYL.BR) stock price today?

As of Dec 19, 2025, 3:36 PM UTC, Hyloris Pharmaceuticals S.A. (HYL.BR) stock is trading at €5.94. The stock price is quoted in EUR and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date HYL.BR stock quotes for informed trading decisions.

What is Hyloris Pharmaceuticals S.A.'s market capitalization?

Hyloris Pharmaceuticals S.A. (HYL.BR) has a market capitalization of approximately $166.3M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Hyloris Pharmaceuticals S.A.'s size relative to other companies in the EUR market. The market cap figure updates automatically as the HYL.BR stock price changes.

What is the 52-week range for Hyloris Pharmaceuticals S.A. stock?

Hyloris Pharmaceuticals S.A. (HYL.BR) stock has traded in a 52-week range of €4.42 — €7.26. The 52-week range shows the highest and lowest prices at which HYL.BR traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Hyloris Pharmaceuticals S.A. stock price to this range provides context for recent price action.

How much trading volume does Hyloris Pharmaceuticals S.A. stock have?

Hyloris Pharmaceuticals S.A. (HYL.BR) stock recently traded approximately 4.6K shares. Trading volume indicates market liquidity and investor interest in HYL.BR. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Hyloris Pharmaceuticals S.A. stock.

Does Hyloris Pharmaceuticals S.A. pay dividends to shareholders?

Yes, Hyloris Pharmaceuticals S.A. (HYL.BR) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Hyloris Pharmaceuticals S.A. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Hyloris Pharmaceuticals S.A.'s intraday price range?

Today, Hyloris Pharmaceuticals S.A. (HYL.BR) stock has traded in a range of €5.94 — €6.04. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring HYL.BR's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Hyloris Pharmaceuticals S.A. stock data?

AlphaPilot sources real-time HYL.BR stock quotes, fundamental financial data, and historical price charts for Hyloris Pharmaceuticals S.A. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Hyloris Pharmaceuticals S.A. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of HYL.BR stock performance.